MOESM2 of Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study

Additional file 2: Table S2. Change from baseline to week 52 in extrapyramidal symptoms scales during AOM 400 maintenance phase

MOESM1 of Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study

Additional file 1: Table S1. Demographic characteristics of study population